Oramed Pharmaceuticals (ORMP)
(Real Time Quote from BATS)
$2.36 USD
+0.02 (0.86%)
Updated Nov 7, 2024 01:42 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | 0.01 |
EPS Last Quarter | 0.22 |
Last EPS Surprise | 2,100.00% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.24 |
Next Year | -0.08 |
EPS (TTM) | 0.10 |
P/E (F1) | 9.75 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.50M | 0.50M | 1.50M | 2.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.50M | 0.50M | 1.50M | 2.00M |
Low Estimate | 0.50M | 0.50M | 1.50M | 2.00M |
Year ago Sales | 0.00M | 0.00M | 1.34M | 1.50M |
Year over Year Growth Est. | NA | NA | 11.94% | 33.33% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.01 | -0.03 | 0.24 | -0.08 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.02 | -0.07 | 0.17 | -0.26 |
High Estimate | 0.03 | 0.02 | 0.31 | 0.10 |
Low Estimate | -0.02 | -0.07 | 0.17 | -0.26 |
Year ago EPS | -0.08 | -0.08 | -0.27 | 0.24 |
Year over Year Growth Est. | 112.50% | 62.50% | 188.89% | -133.33% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.01 | -0.03 | 0.24 | -0.08 |
7 Days Ago | 0.01 | -0.03 | 0.24 | -0.08 |
30 Days Ago | 0.01 | -0.03 | 0.24 | -0.08 |
60 Days Ago | -0.01 | -0.04 | 0.11 | -0.13 |
90 Days Ago | 0.00 | -0.06 | -0.01 | -0.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.01 | -0.03 | 0.24 | -0.08 |
Zacks Consensus Estimate | 0.01 | -0.03 | 0.24 | -0.08 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.22 | 0.04 | -0.08 | -0.08 | NA |
Estimate | 0.01 | 0.02 | -0.12 | -0.09 | NA |
Difference | 0.21 | 0.02 | 0.04 | 0.01 | 0.07 |
Surprise | 2,100.00% | 100.00% | 33.33% | 11.11% | 561.11% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more